Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kirsten M. Pondman"'
Publikováno v:
Drug Metabolism and Personalized Therapy, 33(1), 33-39. De Gruyter
Background:CYP2D6is responsible for the metabolism of approximately 25% of all drugs. The expression of cytochrome P450 2D6 (CYP2D6) is influenced by a combination of factors including polymorphisms in theCYP2D6gene. Analysis of theCYP2D6genotype is
Publikováno v:
Nanoscale Horizons. 2:174-186
The therapeutic application of nanomaterials requires that they are biocompatible and can reach the desired target. The innate immune system is likely to be the first defence machinery that would recognise the nanomaterials as 'non-self'. A number of
Autor:
Jacoline W. Brinkman, An K. Stroobants, Hanneke M. van der Straaten, Cornelis L. Harteveld, Kirsten M. Pondman
Publikováno v:
Hemoglobin, 42(1), 51-53
Hemoglobin, 42(1), 51-53. Informa Healthcare
Hemoglobin, 42(1), 51-53. Informa Healthcare
We report two families, members of which are carriers of a hemoglobin (Hb) variant previously described as Hb Nouakchott [α114(GH2)Pro→Leu; HBA1: c.344C>T; p.Pro115Leu]. In the first family of Dutch origin, the proband, a 32-year-old male and his
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1674a4d4f1d7f3f03d837e5b47250fa6
https://hdl.handle.net/1887/79401
https://hdl.handle.net/1887/79401
Autor:
Uday Kishore, Robert B. Sim, Anthony G. Tsolaki, Bennie ten Haken, Anne Jäkel, Silke Hampel, M.T. Sobik, Annapurna Nayak, Kirsten M. Pondman, Emmanuel Flahaut
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine
Nanomedicine: Nanotechnology, Biology and Medicine, Elsevier, 2014, vol. 10 (n° 6), pp. 1287-1299. ⟨10.1016/j.nano.2014.02.010⟩
Nanomedicine : nanotechnology, biology and medicine, 10(6), 1287-1299. Elsevier
Nanomedicine: Nanotechnology, Biology and Medicine, Elsevier, 2014, vol. 10 (n° 6), pp. 1287-1299. ⟨10.1016/j.nano.2014.02.010⟩
Nanomedicine : nanotechnology, biology and medicine, 10(6), 1287-1299. Elsevier
Carbon nanotubes (CNTs) have promised a range of applications in biomedicine. Although influenced by the dispersants used, CNTs are recognized by the innate immune system, predominantly by the classical pathway of the complement system. Here, we conf
Autor:
Kirsten M, Pondman, Basudev, Paudyal, Robert B, Sim, Anuvinder, Kaur, Lubna, Kouser, Anthony G, Tsolaki, Lucy A, Jones, Carolina, Salvador-Morales, Haseeb A, Khan, Bennie, Ten Haken, Gudrun, Stenbeck, Uday, Kishore
Publikováno v:
Nanoscale. 9(3)
Carbon nanotubes (CNTs) are increasingly being developed for use in biomedical applications, including drug delivery. One of the most promising applications under evaluation is in treating pulmonary diseases such as tuberculosis. Once inhaled or admi
Autor:
Uday Kishore, F. Burcu Celikkol, Bennie ten Haken, Ansar A. Pathan, Johan E. ten Elshof, A. Wouter Maijenburg, Kirsten M. Pondman
Publikováno v:
Journal of materials chemistry. B: materials for biology and medicine, 1(44), 6129-6136. Royal Society of Chemistry
Due to their shape anisotropy, high aspect ratio magnetic nanoparticles offer many advantages in biomedical applications. For biocompatibility, it is essential to have full control over the dimensions and surface chemistry of the particles. The aim o
Autor:
Mohamed H. Shamji, Kirsten M. Pondman, Ten Haken B, Anthony G. Tsolaki, Gudrun Stenbeck, Robert B. Sim, Uday Kishore, Amy Switzer, Suhair M. Abozaid, Basudev Paudyal, Ansar A. Pathan
Publikováno v:
Journal of biomedical nanotechnology, 12(1), 197-216. American Scientific Publishers
Nanoparticles are attractive drug delivery vehicles for targeted organ-specific as well as systemic therapy. However, their interaction with the immune system offers an intriguing challenge to the success of nanotherapeutics in vivo. Recently, we sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7089356b0eee4a29b14fc4488a55e97
https://research.utwente.nl/en/publications/bb63d361-a432-4c49-8769-cb690ba30d0d
https://research.utwente.nl/en/publications/bb63d361-a432-4c49-8769-cb690ba30d0d
Autor:
Leon Abelmann, A. Wouter Maijenburg, Uday Kishore, Johan E. ten Elshof, Bennie ten Haken, Nathan D. Bunt, Kirsten M. Pondman, Richard J. A. van Wezel
Publikováno v:
Journal of Magnetism and Magnetic Materials, 380, 299-306
Journal of magnetism and magnetic materials, 380, 299-306. Elsevier
Journal of Magnetism and Magnetic Materials, 380, pp. 299-306
Journal of magnetism and magnetic materials, 380, 299-306. Elsevier
Journal of Magnetism and Magnetic Materials, 380, pp. 299-306
Magnetic drug delivery is a promising method to target a drug to a diseased area while reducing negative side effects caused by systemic administration of drugs. In magnetic drug delivery a therapeutic agent is coupled to a magnetic nanoparticle. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4ad69e4bc288eb76c12a30cab23a6a2
http://hdl.handle.net/2066/149724
http://hdl.handle.net/2066/149724
Publikováno v:
Encyclopedia of Nanotechnology ISBN: 9789400761780
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0acc33be78d1f0a9048906a7ca64cee4
https://doi.org/10.1007/978-94-007-6178-0_100971-1
https://doi.org/10.1007/978-94-007-6178-0_100971-1